About GenomeWeb Premium

Only GenomeWeb Premium Gives You the Full Story!

GenomeWeb Premium provides exclusive, in-depth coverage of the latest genomic and genetic technologies, life science research trends, and key issues in molecular diagnostics. Premium subscribers get the best of GenomeWeb's original reporting and are able to track the topics of most interest to them.

Premium membership offers unrestricted access across the entire GenomeWeb site. This includes any article featuring the GenomeWeb Premium icon: 

Premium subscribers can opt into any of our weekly topical mailings, which include:

  • Molecular Diagnostics
  • Cancer
  • Infectious Disease
  • Sequencing Technology
  • PCR
  • Informatics
  • Proteomics & Protein Research

Questions? Please contact [email protected] for further information.

Terms of Service for GenomeWeb Premium Licenses

All GenomeWeb content is protected by US and International copyright laws, and may not be copied, reprinted, published, translated, hosted, or otherwise distributed by any means without explicit permission.

Password sharing and redistribution of content are violations of the GenomeWeb Premium license agreement and are monitored. All Premium license users must log in with their own individual work email addresses. Premium users may not store premium articles on an internal or external web page accessible to other users, nor may they email full text or partial text articles to anyone inside or outside the subscribing organization without prior permission of GenomeWeb.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.